CytoMed Therapeutics Limited Transfers Of Research And Development From Entity Related Party Transactions
CytoMed Therapeutics Limited (GDTC) reported Transfers Of Research And Development From Entity Related Party Transactions of SGD 24.17 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions · last filed 2026-03-31
| Period end | Transfers Of Research And Development From Entity Related Party Transactions 12 month |
|---|---|
| 2025-12-31 | 24.17K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 115.28K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 183.52K SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 207.21K SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 50.20K SGD 20-F · filed 2024-04-22 |